Eansor Norman David's Form 4 filing
Marker Therapeutics, Inc. (MRKR) · filed Jun 8, 2023
- Accession no.
- 0001209191-23-035617
- Filed
- Jun 8, 2023
- Trade date
- Mar 16, 2021-Jun 6, 2023
- Filing delay
- 814 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market purchases total $250.0K. It was filed 814 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eansor Norman DavidCIK 0001270905 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | Common Stock | PPurchaseAcquired | +14,285 | $17.50 | +$249,987.5 | 16,713 | Direct | |
| Mar 25, 2021 | Common Stock | GGiftDisposed | −14,285 | $0.00 | $0 | 2,428 | Direct | |
| Mar 25, 2021 | Common Stock | GGiftAcquired | +7,142 | $0.00 | $0 | 7,142 | Indirect | |
| Mar 25, 2021 | Common Stock | GGiftAcquired | +7,142 | $0.00 | $0 | 7,142 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Common Stock | AGrant or awardAcquired | +8,000 | $0.00 | $0 | 8,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.